Approval · Notice of Compliance 16508 · 2015
ISOPTIN SR: Notice of Compliance 16508
Issued January 7, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16508
- Date
- January 7, 2015
- Company
- BGP Pharma ULCEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of durg identification numbers
- Therapeutic class
- Antihypertensive agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ISOPTIN SR | 01907123 | Marketed |
| ISOPTIN SR | 01934317 | Dormant |
| ISOPTIN SR | 00742554 | Dormant |
Medicinal ingredients
- VERAPAMIL HCL 120 MG per TAB
- VERAPAMIL HCL 180 MG per TAB
- VERAPAMIL HCL 240 MG per TAB